仙琚制药(002332) - 2020 Q3 - 季度财报

Financial Performance - Operating revenue for the period was ¥1,162,850,644.68, representing a year-on-year growth of 27.88%[10] - Net profit attributable to shareholders was ¥153,139,417.63, up 30.76% from the same period last year[10] - The total net profit for the year-to-date period reached ¥358,457,332.81, marking a 23.26% increase compared to the same period last year[10] - Basic earnings per share for the period were ¥0.17, reflecting a growth of 30.77% compared to the previous year[10] - The company reported a net profit excluding non-recurring gains and losses of ¥146,763,103.65, which is a 22.44% increase year-on-year[10] - The company reported a net profit of CNY 1,248,481,385.84, up from CNY 981,645,269.63, which is an increase of approximately 27.2%[47] - Net profit for Q3 2020 was CNY 164,432,879.79, representing a 26% increase from CNY 130,796,187.47 in Q3 2019[60] - The net profit for the current period is CNY 378,922,638.64, compared to CNY 326,346,375.05 in the previous period, reflecting an increase of about 16.06%[75] - The company’s net profit attributable to the parent company is CNY 358,457,332.81, compared to CNY 290,822,049.48 in the previous period, reflecting an increase of approximately 23.29%[77] Assets and Liabilities - Total assets at the end of the reporting period reached ¥6,328,685,028.77, an increase of 8.66% compared to the end of the previous year[10] - The company’s total equity attributable to shareholders was ¥3,211,084,810.59, up 9.16% from the previous year[10] - Current liabilities increased to CNY 2,045,695,738.29 from CNY 1,747,205,179.39, representing a rise of about 17.1%[44] - The total liabilities reached CNY 2,984,506,353.88, compared to CNY 2,765,742,131.88, indicating an increase of approximately 7.9%[44] - The total equity attributable to shareholders increased to CNY 3,211,084,810.59 from CNY 2,941,524,857.14, reflecting a growth of about 9.2%[47] - The total liabilities rose to CNY 1,410,343,380.05, compared to CNY 1,159,281,844.07 in the previous year, highlighting increased financial obligations[54] - Total current liabilities stood at CNY 1,747,205,179.39, consistent with the previous period[108] - Total liabilities amounted to CNY 2,765,742,131.88, with non-current liabilities at CNY 1,018,536,952.49[112] Cash Flow - The net cash flow from operating activities was ¥227,652,709.31, a significant increase of 319.56% year-on-year[10] - Cash received from other operating activities increased by 135.54% year-on-year, an increase of 99.7396 million yuan, mainly due to an increase in the recovery of commercial bill deposits[21] - Operating cash inflow for the current period reached CNY 1,204,524,411.77, an increase of 26% compared to CNY 956,511,121.88 in the previous period[96] - Net cash flow from operating activities was CNY 311,076,475.48, up 69% from CNY 183,888,170.93 year-over-year[99] - Cash inflow from financing activities was CNY 651,900,000.00, compared to CNY 612,900,000.00 in the previous period, with a net cash flow of CNY 34,202,404.36[101] Expenses - Total operating costs amounted to CNY 959,595,674.74, up from CNY 754,198,140.59, reflecting a significant increase in operational expenses[57] - Research and development expenses increased to CNY 56,953,663.68, compared to CNY 44,274,125.62 in the previous year, indicating a focus on innovation[57] - The financial expenses for the quarter were CNY 17,961,240.56, an increase from CNY 12,105,359.96, indicating higher borrowing costs[57] - The total operating expenses increased to ¥1,041,652,000.00, up from ¥848,000,000.00 in the previous period, indicating a rise of 23.0%[81] Investment Activities - Investment income decreased by 81.68% year-on-year, a decrease of 17.0816 million yuan, mainly due to the disposal of subsidiaries last year[21] - The investment income for the current period is CNY 3,830,399.88, down from CNY 20,911,953.31 in the previous period, indicating a decrease of about 81.69%[75] - The company’s investment activities generated a net cash outflow of ¥85,412,535.95, an improvement from a net outflow of ¥233,697,979.17 in the previous period[90] Future Outlook - The company plans to continue expanding its market presence and investing in new product development to drive future growth[60]